Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia

Malaria Journal

Volumn 8, Issue 1, 2009, Pages

  Rogers, William O ^a   Sem, Rithy ^b,c   Tero, Thong ^d   Chim, Pheaktra ^c   Lim, Pharath ^c   Muth, Sinuon ^b   Socheat, Duong ^b   Ariey, Frédéric ^c   Wongsrichanalai, Chansuda ^a,e  

^a US Naval Medical Research Unit No 2 Jakarta   (Indonesia)

^b National Malaria Center   (Cambodia)

^c INSTITUT PASTEUR DU CAMBODGE   (Cambodia)

^d Ministry of Health Referral Hospital   (Cambodia)

^e Office of Public Health   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; CHLOROQUINE; GLUTAMATE RICH PROTEIN; MEFLOQUINE; MEROZOITE SURFACE PROTEIN 1; MEROZOITE SURFACE PROTEIN 2; PARASITE ANTIGEN; UNCLASSIFIED DRUG; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; MDR1 PROTEIN, PLASMODIUM FALCIPARUM; MULTIDRUG RESISTANCE PROTEIN;

ADULT; ARTICLE; CAMBODIA; CONTROLLED STUDY; DRUG EFFICACY; DRUG TREATMENT FAILURE; FEMALE; GENE NUMBER; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MONOTHERAPY; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL RATE; ANIMAL; CHILD; CLASSIFICATION; DRUG COMBINATION; GENETICS; IC 50; ISOLATION AND PURIFICATION; METHODOLOGY; PARASITEMIA; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; SURVIVAL; TREATMENT FAILURE;

ADULT; ANIMALS; ANTIMALARIALS; ARTEMISININS; CAMBODIA; CHILD; CHLOROQUINE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INHIBITORY CONCENTRATION 50; MALARIA, FALCIPARUM; MALARIA, VIVAX; MALE; MEFLOQUINE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PARASITEMIA; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; SURVIVAL ANALYSIS; TREATMENT FAILURE;

EID: 58649122842     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-8-10     Document Type: Article

References (22)

1. The public health impact of chloroquine resistance in Africa. JF Trape, Am J Trop Med Hyg 2001 64 12 17 11425173
2. The mortality consequences of the continued use of chloroquine in Africa: experience in Siaya, western Kenya. JR Zucker TK Ruebush C Obonyo J Otieno CC Campbell, Am J Trop Med Hyg 2003 68 386 390 12879851
3. Current malaria status and distribution of drug resistance in East and Southeast Asia with special focus to Thailand. K Na-Bangchang K Congpuong, Tohoku J Exp Med 2007 211 99 113 10.1620/tjem.211.99 17287593
4. In vivo sensitivity monitoring of mefloquine monotherapy and artesunate-mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003. S Vijaykadga C Rojanawatsirivej S Cholpol D Phoungmanee A Nakavej C Wongsrichanalai, Trop Med Int Health 2006 11 211 219 10.1111/j.1365-3156.2005.01557.x 16451346
5. Surveillance of the efficacy of artesunate and mefloquine combination for the treatment of uncomplicated falciparum malaria in Cambodia. MB Denis R Tsuyuoka Y Poravuth TS Narann S Seila C Lim S Incardona P Lim R Sem D Socheat EM Christophel P Ringwald, Trop Med Int Health 2006 11 1360 1366 10.1111/j.1365-3156.2006.01690.x 16930257
6. Antimalarial drug resistance. NJ White, J Clin Invest 2004 113 1084 1092 15085184
7. Assessment and Monitoring of Antimalarial Drug Efficacy for the Treatment of Uncomplicated Falciparum Malaria. World Health Organization, WHO/HTM/RBM/2003.50 Geneva, WHO 2003
8. Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster, Trans R Soc Trop Med Hyg 2000 94 Suppl 1 S1 90 10.1016/S0035-9203(00)90300-6 11103309
9. Plasmodium falciparum parasites in French Guiana: limited genetic diversity and high selfing rate. F Ariey W Chalvet D Hommel C Peneau A Hulin O Mercereau-Puijalon JB Duchemin JL Sarthou JM Reynes T Fandeur, Am J Trop Med Hyg 1999 61 978 985 10674682
10. Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border. AP Alker P Lim R Sem NK Shah P Yi DM Bouth R Tsuyuoka JD Maguire T Fandeur F Ariey C Wongsrichanalai SR Meshnick, Am J Trop Med Hyg 2007 76 641 647 17426163
11. Resistance to antimalarials in Southeast Asia and genetic polymorphisms in pfmdr1. AL Pickard C Wongsrichanalai A Purfield D Kamwendo K Emery C Zalewski F Kawamoto RS Miller SR Meshnick, Antimicrob Agents Chemother 2003 47 2418 2423 12878499 10.1128/AAC.47.8.2418-2423.2003
12. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. RN Price AC Uhlemann A Brockman R McGready E Ashley L Phaipun R Patel K Laing S Looareesuwan NJ White F Nosten S Krishna, Lancet 2004 364 438 447 10.1016/S0140-6736(04)16767-6 15288742
13. Real-time quantitative PCR with SYBR Green I detection for estimating copy numbers of nine drug resistance candidate genes in Plasmodium falciparum. ID Ferreira VE Rosario PV Cravo, Malar J 2006 5 1 16420686 10.1186/1475-2875-5-1
14. Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross. TE Wellems LJ Panton IY Gluzman RV do RW Gwadz A Walker-Jonah DJ Krogstad, Nature 1990 345 253 255 10.1038/345253a0 1970614
15. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. RE Desjardins CJ Canfield JD Haynes JD Chulay, Antimicrob Agents Chemother 1979 16 710 718 394674
16. Amplification of pfmdr 1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand. CM Wilson SK Volkman S Thaithong RK Martin DE Kyle WK Milhous DF Wirth, Mol Biochem Parasitol 1993 57 151 160 10.1016/0166-6851(93)90252-S 8426608
17. Recrudescence in artesunate-treated patients with falciparum malaria is dependent on parasite burden not on parasite factors. W Ittarat AL Pickard P Rattanasinganchan P Wilairatana S Looareesuwan K Emery J Low R Udomsangpetch SR Meshnick, Am J Trop Med Hyg 2003 68 147 152 12641403
18. Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. SR Meshnick TE Taylor S Kamchonwongpaisan, Microbiol Rev 1996 60 301 315 8801435
19. Clinical efficacy and pharmacokinetics of artemisinin monotherapy and in combination with mefloquine in patients with falciparum malaria. MH Alin M Ashton CM Kihamia GJ Mtey A Bjorkman, Br J Clin Pharmacol 1996 41 587 592 8799526 10.1046/j.1365-2125.1996.35116.x
20. Artemisinin for treatment of uncomplicated falciparum malaria: is there a place for monotherapy? PT Giao TQ Binh PA Kager HP Long N Van Thang N Van Nam PJ de Vries, Am J Trop Med Hyg 2001 65 690 695 11791958
21. A randomized trial of artemether-lumefantrine versus mefloquine- artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of Thailand. R Hutagalung L Paiphun EA Ashley R McGready A Brockman KL Thwai P Singhasivanon T Jelinek NJ White FH Nosten, Malar J 2005 4 46 16179089 10.1186/1475-2875-4-46
22. Therapeutic efficacy of artemether-lumefantrine and artesunate-mefloquine for treatment of uncomplicated Plasmodium falciparum malaria in Luang Namtha Province, Lao People's Democratic Republic. JM Stohrer S Dittrich V Thongpaseuth V Vanisaveth R Phetsouvanh S Phompida F Monti EM Christophel N Lindegardh A Annerberg T Jelinek, Trop Med Int Health 2004 9 1175 1183 10.1111/j.1365-3156. 2004.01320.x 15548313